Offer - Urjas Oil for just ₹ 1 X
Clomifene + Coenzyme Q10 is an allopathic medicine The correct dosage of Clomifene + Coenzyme Q10 depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Clomifene + Coenzyme Q10 is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Based on research, the following side effects have been observed when Clomifene + Coenzyme Q10 is used -
Severe
Mild
Common
Is the use of Clomifene + Coenzyme Q10 safe for pregnant women?
The effects of Clomifene + Coenzyme Q10 on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Clomifene + Coenzyme Q10 safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Clomifene + Coenzyme Q10 for breastfeeding women are not known.
What is the effect of Clomifene + Coenzyme Q10 on the Kidneys?
Using Clomifene + Coenzyme Q10 does not have any harmful effects on kidneys.
What is the effect of Clomifene + Coenzyme Q10 on the Liver?
Clomifene + Coenzyme Q10 is rarely harmful for the liver.
What is the effect of Clomifene + Coenzyme Q10 on the Heart?
Clomifene + Coenzyme Q10 may have mild side effects on the heart. Most people will never see any effect on the heart.
Clomifene + Coenzyme Q10 should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Clomifene + Coenzyme Q10 unless your doctor advises you to do so -
Is this Clomifene + Coenzyme Q10 habit forming or addictive?
Clomifene + Coenzyme Q10 does not cause addiction.
Interaction between Food and Clomifene + Coenzyme Q10
You can take Clomifene + Coenzyme Q10 with food.
Interaction between Alcohol and Clomifene + Coenzyme Q10
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Clomifene + Coenzyme Q10.
Yes, Clomifene + Coenzyme Q10 and Provera (medroxyprogesterone) can be taken together. No harmful drug interaction has been reported between them. Hence it is alright to take them together. However, if you feel any discomfort after taking this drug along with Provera then do not hesitate to inform your doctor.
No, Clomifene + Coenzyme Q10 does not cause hormonal imbalance. In fact, it helps in regulating the hormonal imbalance caused by immature ovarian follicles.
Yes, Clomifene + Coenzyme Q10 may cause twins (multiple pregnancies). It occurs because Clomifene + Coenzyme Q10 increases the possibility of releasing multiple eggs from the ovaries (multiple ovulation). However, the chances of having twins due to this drug are less than 1 out of 10 pregnancies.
Usually, Clomifene + Coenzyme Q10 is given for short-term treatment up to 5 days if ovulation is not induced then this same treatment course is started after the interval of 30 days at higher doses. You are advised to take Clomifene + Coenzyme Q10 as long as it is recommended by your doctor. Taking this drug beyond that period might not be good for you because it can lead to unintended side effects.
Rarely, Clomifene + Coenzyme Q10 causes depression. However, the exact cause of depression is not known. If you are experiencing insomnia, persistent feeling of sadness, loss of appetite, loss of interest in activities which are symptoms of depression then you are advised to discuss it with your doctor without any further delay.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Clomid® (clomiphene citrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 312